Levetiracetam Affects Differentially Presynaptic Proteins in Rat Cerebral Cortex
Presynaptic proteins are potential therapeutic targets for epilepsy and other neurological diseases. We tested the hypothesis that chronic treatment with the SV2A ligand levetiracetam affects the expression of other presynaptic proteins. Results showed that in rat neocortex no significant difference...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-12-01
|
Series: | Frontiers in Cellular Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fncel.2017.00389/full |
id |
doaj-20e079830db042a8a71149e78bf1e626 |
---|---|
record_format |
Article |
spelling |
doaj-20e079830db042a8a71149e78bf1e6262020-11-24T22:20:52ZengFrontiers Media S.A.Frontiers in Cellular Neuroscience1662-51022017-12-011110.3389/fncel.2017.00389296390Levetiracetam Affects Differentially Presynaptic Proteins in Rat Cerebral CortexDaniele Marcotulli0Giorgia Fattorini1Giorgia Fattorini2Luca Bragina3Luca Bragina4Jessica Perugini5Fiorenzo Conti6Fiorenzo Conti7Department of Experimental and Clinical Medicine, Università Politecnica delle Marche, Ancona, ItalyDepartment of Experimental and Clinical Medicine, Università Politecnica delle Marche, Ancona, ItalyCenter for Neurobiology of Aging, INRCA IRCCS, Ancona, ItalyDepartment of Experimental and Clinical Medicine, Università Politecnica delle Marche, Ancona, ItalyCenter for Neurobiology of Aging, INRCA IRCCS, Ancona, ItalyDepartment of Experimental and Clinical Medicine, Università Politecnica delle Marche, Ancona, ItalyDepartment of Experimental and Clinical Medicine, Università Politecnica delle Marche, Ancona, ItalyCenter for Neurobiology of Aging, INRCA IRCCS, Ancona, ItalyPresynaptic proteins are potential therapeutic targets for epilepsy and other neurological diseases. We tested the hypothesis that chronic treatment with the SV2A ligand levetiracetam affects the expression of other presynaptic proteins. Results showed that in rat neocortex no significant difference was detected in SV2A protein levels in levetiracetam treated animals compared to controls, whereas levetiracetam post-transcriptionally decreased several vesicular proteins and increased LRRK2, without any change in mRNA levels. Analysis of SV2A interactome indicates that the presynaptic proteins regulation induced by levetiracetam reported here is mediated by this interactome, and suggests that LRRK2 plays a role in forging the pattern of effects.http://journal.frontiersin.org/article/10.3389/fncel.2017.00389/fulllevetiracetamvesicular transport proteinsSV2Apresynaptic proteinsinteractomeLRRK2 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Daniele Marcotulli Giorgia Fattorini Giorgia Fattorini Luca Bragina Luca Bragina Jessica Perugini Fiorenzo Conti Fiorenzo Conti |
spellingShingle |
Daniele Marcotulli Giorgia Fattorini Giorgia Fattorini Luca Bragina Luca Bragina Jessica Perugini Fiorenzo Conti Fiorenzo Conti Levetiracetam Affects Differentially Presynaptic Proteins in Rat Cerebral Cortex Frontiers in Cellular Neuroscience levetiracetam vesicular transport proteins SV2A presynaptic proteins interactome LRRK2 |
author_facet |
Daniele Marcotulli Giorgia Fattorini Giorgia Fattorini Luca Bragina Luca Bragina Jessica Perugini Fiorenzo Conti Fiorenzo Conti |
author_sort |
Daniele Marcotulli |
title |
Levetiracetam Affects Differentially Presynaptic Proteins in Rat Cerebral Cortex |
title_short |
Levetiracetam Affects Differentially Presynaptic Proteins in Rat Cerebral Cortex |
title_full |
Levetiracetam Affects Differentially Presynaptic Proteins in Rat Cerebral Cortex |
title_fullStr |
Levetiracetam Affects Differentially Presynaptic Proteins in Rat Cerebral Cortex |
title_full_unstemmed |
Levetiracetam Affects Differentially Presynaptic Proteins in Rat Cerebral Cortex |
title_sort |
levetiracetam affects differentially presynaptic proteins in rat cerebral cortex |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Cellular Neuroscience |
issn |
1662-5102 |
publishDate |
2017-12-01 |
description |
Presynaptic proteins are potential therapeutic targets for epilepsy and other neurological diseases. We tested the hypothesis that chronic treatment with the SV2A ligand levetiracetam affects the expression of other presynaptic proteins. Results showed that in rat neocortex no significant difference was detected in SV2A protein levels in levetiracetam treated animals compared to controls, whereas levetiracetam post-transcriptionally decreased several vesicular proteins and increased LRRK2, without any change in mRNA levels. Analysis of SV2A interactome indicates that the presynaptic proteins regulation induced by levetiracetam reported here is mediated by this interactome, and suggests that LRRK2 plays a role in forging the pattern of effects. |
topic |
levetiracetam vesicular transport proteins SV2A presynaptic proteins interactome LRRK2 |
url |
http://journal.frontiersin.org/article/10.3389/fncel.2017.00389/full |
work_keys_str_mv |
AT danielemarcotulli levetiracetamaffectsdifferentiallypresynapticproteinsinratcerebralcortex AT giorgiafattorini levetiracetamaffectsdifferentiallypresynapticproteinsinratcerebralcortex AT giorgiafattorini levetiracetamaffectsdifferentiallypresynapticproteinsinratcerebralcortex AT lucabragina levetiracetamaffectsdifferentiallypresynapticproteinsinratcerebralcortex AT lucabragina levetiracetamaffectsdifferentiallypresynapticproteinsinratcerebralcortex AT jessicaperugini levetiracetamaffectsdifferentiallypresynapticproteinsinratcerebralcortex AT fiorenzoconti levetiracetamaffectsdifferentiallypresynapticproteinsinratcerebralcortex AT fiorenzoconti levetiracetamaffectsdifferentiallypresynapticproteinsinratcerebralcortex |
_version_ |
1725773423367421952 |